Orgenesis Price on October 1, 2024

ORGSDelisted Stock  USD 1.22  0.31  20.26%   
If you're considering investing in Orgenesis OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Orgenesis stands at 1.22, as last reported on the 22nd of December, with the highest price reaching 1.55 and the lowest price hitting 1.10 during the day. Orgenesis maintains Sharpe Ratio (i.e., Efficiency) of -0.29, which implies the firm had a -0.29% return per unit of risk over the last 3 months. Orgenesis exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Orgenesis' Variance of 127.61, coefficient of variation of (587.98), and Risk Adjusted Performance of (0.13) to confirm the risk estimate we provide.
  
Orgenesis OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.289

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsORGS

Estimated Market Risk

 13.72
  actual daily
96
96% of assets are less volatile

Expected Return

 -3.96
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.29
  actual daily
0
Most of other assets perform better
Based on monthly moving average Orgenesis is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Orgenesis by adding Orgenesis to a well-diversified portfolio.

Related Headline

Acrivon Therapeutics, Headline on 1st of October 2024

Filed transaction by Acrivon Therapeutics, Common Officer: Chief Legal Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Orgenesis Valuation on October 1, 2024

It is possible to determine the worth of Orgenesis on a given historical date. On October 1, 2024 Orgenesis was worth 4.49 at the beginning of the trading date compared to the closed value of 4.48. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Orgenesis otc stock. Still, in general, we apply an absolute valuation method to find Orgenesis' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Orgenesis where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Orgenesis' related companies.
 Open High Low Close Volume
  5.20    5.20    4.21    4.46    52,386  
10/01/2024
  4.49    4.79    4.23    4.48    46,884  
  4.49    4.50    4.27    4.42    5,169  
Backtest Orgenesis  |  Orgenesis History  |  Orgenesis Valuation   PreviousNext  
Open Value
4.49
4.48
Closing Value
45.64
Upside

Orgenesis Trading Date Momentum on October 1, 2024

On October 02 2024 Orgenesis was traded for  4.42  at the closing time. The top price for the day was 4.50  and the lowest listed price was  4.27 . The trading volume for the day was 5.2 K. The trading history from October 2, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.34% . The trading delta at closing time against the current closing price is 15.18% .

Orgenesis Fundamentals Correlations and Trends

By evaluating Orgenesis' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Orgenesis' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Orgenesis financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Orgenesis OTC Stock history

Orgenesis investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Orgenesis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Orgenesis will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Orgenesis stock prices may prove useful in developing a viable investing in Orgenesis
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland. Orgenesis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 151 people.

Orgenesis OTC Stock Technical Analysis

Orgenesis technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Orgenesis technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Orgenesis trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Orgenesis Period Price Range

Low
December 22, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Orgenesis cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Orgenesis December 22, 2024 Market Strength

Market strength indicators help investors to evaluate how Orgenesis otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Orgenesis shares will generate the highest return on investment. By undertsting and applying Orgenesis otc stock market strength indicators, traders can identify Orgenesis entry and exit signals to maximize returns

Orgenesis Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Orgenesis' price direction in advance. Along with the technical and fundamental analysis of Orgenesis OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Orgenesis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price.
Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Consideration for investing in Orgenesis OTC Stock

If you are still planning to invest in Orgenesis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orgenesis' history and understand the potential risks before investing.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Valuation
Check real value of public entities based on technical and fundamental data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities